Eurofins BioPharma Services Newsletter 33 - October 2022
ARTICLES:
- Detection of mycobacterium species in qPCR as a consideration for cell banking testing in support of cell & gene therapy manufacturing
- Eurofins enhances vaccine development services
- Simplifying the audit process for drug manufacturers
- Eurofins BPT Italy expands efficacy testing capacity and capabilities against viruses
- Testing for rouge metals can help make pharmaceutical water and final drug products safer for patients
- Ready for MDR? Last chance to identify and close gaps in your documentation
Download the PDF version of pharma newsletter N°33
